NCT02394769View on ClinicalTrials.gov

ASPirin Intervention for the REDuction of Colorectal Cancer Risk

NAActive, not recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 6, 2015

Primary Completion Date

April 11, 2019

Study Completion Date

July 31, 2029

Conditions
Colorectal Cancer
Interventions
DRUG

Aspirin

DRUG

Placebo for Aspirin

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT02394769 - ASPirin Intervention for the REDuction of Colorectal Cancer Risk | Biotech Hunter | Biotech Hunter